No Detail Found!

Estimation of Pax8/ppar Fusion Gene by Fish Technique in Follicular Thyroid Lesions.

Author(s)
BanJ Qasim Department of Pathology, College of Medicine, Al-Nahrain University, Baghdad, Iraq
AlaaG Hussein Department of Pathology, College of Medicine, Al-Nahrain University, Baghdad, Iraq
WijdanB Abid Department of Biology, College of Education for Pure Sciences (Ibn Al-Haitham), University of Baghdad, Baghdad, Iraq
Buthinah I Hameed College of Pharmacy, Mustansiryah University, Baghdad, Iraq
Abstract
The purpose of the study was to detect PAX8/PPAR G gene rearrangement by fluorescent in situ hybridization (FISH) technique, the present study is the first time in Iraq used this technique to detect fusion gene in follicular thyroid lesions, follicular carcinoma (FC) follicular variant papillary of carcinoma (FVPC), follicular adenoma (FA) and follicular hyperplasia. A total of 120 paraffin block were included in the study, 30 blocks were (FC), 30 blocks were (FVPC). 30 blocks were (FA), 30 blocks were blocks thyroid follicular hyperplasia.20 blocks endocervical epithelium.20 paraffin blocks of colonic epithelium. The clinicopathological parameters were obtained from patients' admission case sheets and pathology reports (age, gender). The description of measures regarding fluorescent instu hybridization of PAX8/ PPAR G fusion gene there was significantly highest in follicular carcinoma, followed by follicular variant of papillary carcinoma, then follicular adenoma and lastly by follicular hyperplasia The area under the curve for all three markers was >0.8.The p-value was highly significant for all three markers (P1 for Galectin-3 marker, score of >2 for HBME-1 marker and number of positive cells per 50 of >13 (>26%) for PAX8 /PPAR G fusion gene marker. The sensitivities for the three markers were 100.00 %, 90.00 % and 66.67 %, respectively, whereas the specificities were 88.30 %, 98.33 % and 100.00 % respectively.
Publication Details
Page(s) 653-658
DOI DOI not available
Published Journal: Pakistan Journal of Biotechnology, Volume: 15, Issue: 3, Year: 2018

Request the full text from PASTIC

References
Algeciras-Schimnich , A.,Milosevic , D.,McIver , B.,Flynn , H.,Reddi , H.V.,EberhardtN.L.,S.K.Grebe, 2010.Evaluation of the PAX8/PPARG Translocation in Follicular Thyroid Cancer with a 4-Color Reverse-Transcription PCR Assay and Automated High-Resolution Fragment Analysis,Clin. Chem 56 391 -398
Castro , P.,Rebocho , A.P.,Soares , R.J.,Magalhães , J.,Roque , L.,Trovisco , V.,I. , Cardoso-de-Oliveira,M. , Fonseca,E. , Soares,P.,M.Sobrinho-Simões, 2006.PAX8- PPARγ rearrange-ment is frequently detected in the follicular variant of papillary thyroid carcinoma,J. Clin. Endocrin. Met 91 213 -220
Dwight , T.,Thoppe , S.R.,Foukakis , T.,Lui , W. O.,Wallin , G.,Höög , A.,Frisk , T.,Larsson , C.,J. Zedenius, 2003.Involvement of the PAX8/ peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors,J. Clin. Endo-crinol. Metab 88 4440 -5
Eberhardt , N. L.,Grebe , S. K.,McIver , B. and H.V.,Reddi, 2010.The role of the PAX8/PPAR gamma fusion oncogene in the pathogenesis of follicular thyroid cancer,Mol. Cell. Endocrinol 321 50 -56
GómezSáez,J.M., 2011.Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer,Current Genomics 12 597 -608
Jadhav , S.,Lila , A.,Bandgar , T.,N.Shah, 2012.Promise and pitfalls of molecular markers of thyroid nodules,Indian. J. Endocrin. Met 16 S162 -S166
Kondo , T.,Ezzat , S. and S.L.,Asa, 2006.Pathogenetic mechanisms in thyroid follicular-cell neoplasia,Nat. Rev. Cancer 6 292 -306
Lui , W.O.,Zeng , L.,Rehrmann , V.,Deshpande , S.,Tretiakova , M.,Kaplan , E.L.,Leibiger , I.,Leibiger , B.,Enberg , U.,Hoog , A.,Larsson , C., 2008.-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis,Cancer Res 68 7156 -7164
Popoveniuc , G.,J.Jonklaas,ThyroidNodules, 2012., 96 329 -349
Roberts , P.J. and C.J.,Der, 2007.Targeting the RafMEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer,Oncogene 26 3291 -3310
Ross , D.S.,Litofsky , D.,Ain , K.B.,Bigos , T.,Brierley , J.D.,Cooper , D.S.,Haugen , B.R.,Jonklaas , J.,Ladenson , P.W.,Magner , J.,Robbins , J.,Skarulis , M.C.,Steward , D.L.,Maxon , H.R. and S.I. Sherman, 2009.Recurrence after treatment of micropapillary thyroid cancer,Thyroid 19 1043 -1048
0

Citations

0

Downloads

60

Views